title: Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease.
abstract: Gaucher disease (OMIM #230800) is caused by β-glucosidase deficiency and primarily involves the mononuclear phagocyte system (also called Reticuloendothelial System or Macrophage System). The disease is classified into three main phenotypes based on the presence or absence of neurological manifestations: non-neuronopathic (type 1), acute neuronopathic (type 2) and chronic neuronopathic (type 3). Typical manifestations include hepatosplenomegaly, skeletal deformities, hematological abnormalities, interstitial lung fibrosis and neurodegeneration in neuronopathic cases. Mesenteric lymphadenopathy with resultant protein losing enteropathy (PLE) has only been rarely described. Mesenteric lymphadenopathy may lead to intestinal lymphatic obstruction and secondary lymphangiectasia resulting in chronic diarrhea, abdominal pain and weight loss. Fecal protein loss with secondary hypoalbuminemia can be significant. We report a male with Chronic Neuronopathic Gaucher disease (GD) (homozygous for c.1448T > C (NM_000157.3) GBA mutation) who at 16 years of age developed intractable abdominal pain, diarrhea and weight loss. This was caused by PLE secondary to intestinal lymphangiectasia caused by calcified mesenteric lymphadenopathy despite prior long term enzyme replacement therapy (ERT) and/or substrate reduction therapy (SRT). His older similarly affected sister who had been receiving treatment with ERT and/or SRT remains stable on these treatments with no evidence of mesenteric lymphadenopathy. Medical management with total parenteral nutrition, daily medium chain triglyceride-oil (MCT) supplementation, low dose oral budesonide, continued oral SRT and an increased dose of parenteral ERT has stabilized his condition with resolution of the gastrointestinal symptoms and appropriate weight gain.
authors.affiliation: Department of Pediatrics and Child Health, University of Manitoba, Canada; Department of Biochemistry and Medical Genetics, University of Manitoba, Canada.
authors.forename: A A
authors.initials: AA
authors.lastname: Mhanni
authors.affiliation: Department of Pediatrics, McMaster University, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Kozenko
authors.affiliation: Department of Biochemistry and Medical Genetics, University of Manitoba, Canada.
authors.forename: J N
authors.initials: JN
authors.lastname: Hartley
authors.affiliation: Department of Pediatrics, University of Utah, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Deneau
authors.affiliation: Department of Pediatrics and Child Health, University of Manitoba, Canada.
authors.forename: W
authors.initials: W
authors.lastname: El-Matary
authors.affiliation: Department of Pediatrics and Child Health, University of Manitoba, Canada; Department of Biochemistry and Medical Genetics, University of Manitoba, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Rockman-Greenberg